TY  - JOUR
AU  - Sereno, María
AU  - Gutiérrez-Gutiérrez, Gerardo
AU  - Rubio, Juan Moreno
AU  - Apellániz-Ruiz, María
AU  - Sánchez-Barroso, Lara
AU  - Casado, Enrique
AU  - Falagan, Sandra
AU  - López-Gómez, Miriam
AU  - Merino, María
AU  - Gómez-Raposo, César
AU  - Rodriguez-Salas, Nuria
AU  - Tébar, Francisco Zambrana
AU  - Rodriguez Antona, Cristina
PY  - 2017
DO  - 10.1186/s12885-016-3031-5
SN  - 1471-2407
UR  - http://hdl.handle.net/20.500.12105/7434
AB  - BACKGROUND: Oxaliplatin is a chemotherapy agent active against digestive tumors. Peripheral neuropathy is one of the most important dose-limiting toxicity of this drug. It occurs in around 60-80% of the patients, and 15% of them develop severe...
LA  - eng
PB  - BioMed Central (BMC)
KW  - Calcium channel
KW  - Oxaliplatin neuropathy
KW  - SCN9A
KW  - Adult
KW  - Aged
TI  - Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy
TY  - journal article
ER  -